B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.

PLoS One · 2015 · PMC4488509 · PMID 26132314

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

at 6, 10, 15, 20, 24 and 36 months, there were highly significant differences in “SF-36mean5” scores as compared to baseline, for all patients, and for major and moderate responders ( Fig 6A, and 6C ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.